Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07270211 · ClinicalTrials.gov registry record
MCG In Long QT Syndrome
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 100
- Enrollment target
NCT07270211: Clinical Trial study, sponsored by Mayo Clinic.
NCT07270211 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07270211 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 100 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG. The primary safety objective is to characterize the safety profile of the CardiAQ MCG device.
Primary Outcome
Dofetilide loading is considered successful if the following conditions are met: 1. No excessive QTc prolongation QTc remains \<500 ms, and no \>15% increase from baseline. 2. No sustained VT or recurrent/symptomatic non-sustained VT (NSVT) suggestive of proarrhythmia. 3. No symptomatic bradycardia or hemodynamic instability 4. Stable renal function 5. No deterioration necessitating dose reduction or discontinuation. 6. Discharge on a stable dose
Interventions
- DIAGNOSTIC_TEST Magnetocardiography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04 |
| Est. Completion | 2027-12 |
What is known before NCT07270211 opens enrollment
NCT07270211 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Magnetocardiography is the first listed.
NCT07270211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07270211 about?
NCT07270211 is a clinical study titled "MCG In Long QT Syndrome". The primary objective of this observational study is to evaluate whether magnetocardiography (MCG) findings more accurately predict clinical outcomes in patients with acquired Long QT syndrome compared to ECG. The secondary objective is to assess differences in QT interval length between MCG and ECG...
What is the current status of trial NCT07270211?
This trial is currently not yet recruiting. The enrollment target is 100 participants. The study started on 2026-04. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07270211?
The interventions under investigation include: Magnetocardiography (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07270211?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia